Nicholas T. Hertz, Ph.D., is the Founder and CEO of Montara Therapeutics, a seed-stage biotechnology company developing therapies for brain diseases by leveraging its proprietary BrainOnly™ platform. This CNS-targeting technology, developed in the Shokat Lab at UCSF, enhances drug safety and efficacy and enables modulation of previously undruggable targets.

We congratulate our researchers, Kevan Shokat and Ziyang Zhang, on whose technology this company was founded.

Read the Hertz interview